Share Email Print

Proceedings Paper

Mechanism Of Tumor Localization And Therapy By Derivatives Of Hematoporphyrin
Author(s): David Kessel
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The tumor-localizing product HPD (hematoporphyrin derivative) contains both monomer and dimer/oligomer components. The former are potent photosensitizers in cell-free systems and, in some cases, in cell culture. But these porphyrins are poorly retained by neoplastic cells in vivo. Tumor localization derives from the presence, in HPD, of a series of covalently-bound hematoporphyrin dimers and oligomers which are joined by ester and ether linkages. Like many non-localizing porphyrins, these products can bind to circulating low-density lipoprotein and enter cells via LDL receptors. The initial step in tumor localization results from the presence of elevated levels of LDL receptors on the surface of neoplastic cells. But retention of the HP dimer/oligomer fraction results in long-term photosensitization. The preferential dye accumulation in mitochondria cannot be attributed to the presence of specific porphyrin receptors, but may instead result from the ability of the porphyrin dimer/oligomer fraction to undergo a conformational change as a function of its environment. These changes were probed in micellar and pre-micellar systems and the results show the HP dimer/oligomers to have properties not shared by porphyrin monomers.

Paper Details

Date Published: 19 February 1988
PDF: 7 pages
Proc. SPIE 0847, New Directions in Photodynamic Therapy, (19 February 1988); doi: 10.1117/12.942702
Show Author Affiliations
David Kessel, Wayne State University School of Medicine and Harper Hospital (United States)

Published in SPIE Proceedings Vol. 0847:
New Directions in Photodynamic Therapy
Douglas C. Neckers, Editor(s)

© SPIE. Terms of Use
Back to Top